AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcrip

AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript

AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript February 15, 2024 AtriCure, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.22. AtriCure, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and welcome to AtriCure’s Fourth […]

Related Keywords

United States , Angela Wirick , Angie Wirick , Michael Carrel , Atriclip Flex , Chief Financial , Atriclip Flexv , Cancer Treatment , Atricure , Nc , Market Opportunity , Revenue Growth , Fourth Quarter , Pain Management , Clinical Trial ,

© 2024 Vimarsana